AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

amoxicillin trihydrate, Quantity: 574 mg (Equivalent: amoxicillin, Qty 500 mg); potassium clavulanate, Quantity: 148.9 mg (Equivalent: clavulanic acid, Qty 125 mg)

Disponible des:

Southern Cross Pharma Pty Ltd

Designació comuna internacional (DCI):

amoxicillin trihydrate,potassium clavulanate

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: microcrystalline cellulose; methylcellulose; dimeticone 100; colloidal anhydrous silica; purified talc; magnesium stearate; titanium dioxide; sodium starch glycollate; diethyl phthalate

Vía de administración:

Oral

Unidades en paquete:

10 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Amoxicillin and clavulanic acid tablets are indicated for short-term treatment of bacterial infections at the following sites when caused by sensitive organisms: - Urinary tract infections (uncomplicated and complicated). - Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis. - Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis. - Skin and skin structure infections. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Amoxyclave Duo SCP and Amoxyclave Duo Forte SCP tablets. However, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in Microbiology, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Amoxyclave Duo SCP and Amoxyclave Duo Forte Scp tablets should not require the addition of another antibiotic due to the amoxycillin content of these products.

Resumen del producto:

Visual Identification: White convex capsule shaped film coated tablet; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2016-07-12